Insider: Greenstreet Yvonne Chief Executive Officer - ALNYLAM PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 98,364 | 0 | 98,364 |
| Value | $31,363,361.40 | $0.00 | $31,363,361.40 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/04/2026 | DDS | 129 | Direct | COM | $320.01 | $41,281.29 | 98,364 |
| 03/04/2026 | DDS | 135 | Direct | COM | $319.03 | $43,069.05 | 98,493 |
| 03/04/2026 | DDS | 265 | Direct | COM | $325.67 | $86,302.55 | 95,695 |
| 03/04/2026 | DDS | 368 | Direct | COM | $321.82 | $118,429.76 | 97,722 |
| 03/04/2026 | DDS | 274 | Direct | COM | $320.81 | $87,901.94 | 98,090 |
| 03/04/2026 | DDS | 973 | Direct | COM | $323.84 | $315,096.32 | 96,305 |
| 03/04/2026 | DDS | 345 | Direct | COM | $324.88 | $112,083.60 | 95,960 |
| 03/04/2026 | DDS | 444 | Direct | COM | $323.01 | $143,416.44 | 97,278 |
| 03/02/2026 | DDS | 1,098 | Direct | COM | $325.63 | $357,541.74 | 103,747 |
| 03/02/2026 | DDS | 382 | Direct | COM | $324.65 | $124,016.30 | 104,845 |
| 03/02/2026 | DDS | 200 | Direct | COM | $323.62 | $64,724.00 | 105,227 |
| 03/02/2026 | DDS | 1,399 | Direct | COM | $327.67 | $458,410.33 | 100,679 |
| 03/02/2026 | DDS | 1,669 | Direct | COM | $326.81 | $545,445.89 | 102,078 |
| 03/02/2026 | DDS | 399 | Direct | COM | $331.93 | $132,440.07 | 98,788 |
| 03/02/2026 | DDS | 346 | Direct | COM | $330.85 | $114,474.10 | 99,187 |
| 03/02/2026 | DDS | 722 | Direct | COM | $329.71 | $238,050.62 | 99,533 |
| 03/02/2026 | DDS | 424 | Direct | COM | $328.71 | $139,373.04 | 100,255 |
| 03/02/2026 | DDS | 160 | Direct | COM | $332.64 | $53,222.40 | 98,628 |
| 02/13/2026 | DDS | 6,958 | Direct | COM | $310.08 | $2,157,542.21 | 85,662 |
| 01/12/2026 | DDS | 980 | Direct | COM | $360.22 | $353,015.60 | 84,307 |
| 01/12/2026 | DDS | 624 | Direct | COM | $361.45 | $225,544.80 | 83,683 |
| 01/12/2026 | DDS | 464 | Direct | COM | $362.38 | $168,144.32 | 83,219 |
| 01/12/2026 | DDS | 301 | Direct | COM | $363.55 | $109,428.55 | 82,918 |
| 01/12/2026 | DDS | 537 | Direct | COM | $359.14 | $192,858.18 | 85,287 |
| 01/12/2026 | DDS | 269 | Direct | COM | $355.16 | $95,538.04 | 87,472 |
| 1 2 3 4 5 6 7 Next Last You are at page 1 of 7 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research